Deciphera Pharmaceuticals (DCPH) Tops Q3 EPS by 17c

November 5, 2020 5:21 PM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q3 EPS of ($1.13), $0.17 better than the analyst estimate of ($1.30). Revenue for the quarter came in at $15.5 million versus the consensus estimate of $7.05 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities